Trader Makes Over $1.5 Million In Shorts as Optimism Price Continues to Dip, Invests $200K in Algotech Presale

The dynamism of the crypto market that allows traders to benefit from the rise or fall of a cryptocurrency is part of the allure advancing the adoption of digital coins. While many investors want to see their investments rise, some won’t mind shifting positions if there’s an opportunity for profit in a decline. One such investor made over $1.5 million from a short position he held on Optimism Price and has made the news for where he invested 13% of his earnings: Algotech (ALGT). Why Algotech? Let’s find out more.

Optimism Price Drops, trader takes advantage for massive gains

Optimism (OP) has seen a persistent decline over the last couple of days. On May 4, after hitting a high of $3.03, OP failed to hold any solid ground as it fell all the way to $2.27, losing approximately 25%. Some investors are still holding on to their OP investment in good faith while some traders decided to trade against the coin as the market signaled a decline.

One such trader, whose identity remains anonymous. made over $1.5 million from this OP short. This news is coming in a time of uncertainty for the Ethereum layer-2 solution. Analysts believe there is no clear direction yet on the chart where OP price could go, so a lot of observation and caution will have to be applied in this season.

According to this anonymous trader, he said, “The fundamentals aren’t just there for Optimism Price right now.” He also noted that part of what validated his short move on OP was the persistent high gas fees on Ethereum and increasing competition for layer-2 solutions on Ethereum—things were generally not looking promising and he took a shot.

The heat around Algotech (ALGT) increases as trader injection funds

Algotech has already been in the headlines for its successful presale ongoing at stage 3. With over $4.8 million acquired from sales so far, Algotech has shown a strong level of investors confidence in its project. The heat around this presale just got hotter as this anonymous trader has allocated $200,000 to Algotech’s presale, showing confidence in ALGT’s potential.

Algotech is building a robust decentralized crypto algorithmic trading platform with the aim to revolutionize trading and investments as we currently know it. Building a decentralized algorithmic trading platform means that every trader can now easily access algorithmic trading tools that were once exclusive to big financial players. This also means a platform that empowers traders of all kinds with what they need to navigate the crypto market more profitably.

But Algotech’s allure doesn’t just come from all that. Its talking point is its integration of artificial intelligence and machine learning into its proprietary algorithmic trading software to enhance the efficiency, accuracy, and speed of execution for advanced strategies like mean reversion, trend following, breakout trading, arbitraging, etc., that Algotech plans to offer traders.

To learn more about Algotech, visit the Algotech presale website or join the Algotech community.

Key Takeaway

An anonymous trader gained over $1.5 million from an OP short  amid its price decline and allocated $200,000 in Algotech’s (ALGT) presale. Algotech has been a buzz word for its decentralized crypto algorithmic trading platform, amd its integration of AI and machine learning to enhance trading efficiency and profitability.

Disclaimer: This is a paid release. The statements, views and opinions expressed in this column are solely those of the content provider and do not necessarily represent those of NewsBTC. NewsBTC does not guarantee the accuracy or timeliness of information available in such content. Do your research and invest at your own risk.

Disclaimer: The information found on NewsBTC is for educational purposes only. It does not represent the opinions of NewsBTC on whether to buy, sell or hold any investments and naturally investing carries risks. You are advised to conduct your own research before making any investment decisions. Use information provided on this website entirely at your own risk.

Premium Partners

Newsletter